Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top psychiatric drugs in the United States by sales 2016

Selected top psychiatric drugs' U.S. revenue in 2016 (in million U.S. dollars)

Top psychiatric drugs in the United States by sales 2016 This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.
Show more

Selected top psychiatric drugs' U.S. revenue in 2016 (in million U.S. dollars)

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.
Show more
Release date
April 2017
Region
United States
Survey time period
2016
Supplementary notes
This statistic was assembled from several sources.
* Includes sales from Bristol-Myers Squibb and Otsuka (Abilify+Abilify Maintena).
Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical brands: Cymbalta (Eli Lilly)
Pharmaceutical brands: Cymbalta (Eli Lilly)

All Information
in one Presentation

Pharmaceutical brands: Cymbalta (Eli Lilly)

Everything On "Pharmaceutical brands: Cymbalta (Eli Lilly)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Top pharmaceutical drugs"
  • Global overview
  • Select therapy classes - global
  • U.S. overview
  • Select therapy classes - U.S.
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.